Cycurion announced a 1-for-8 reverse stock split to address NASDAQ listing requirements. The action was detailed in a shareholder letter from the CEO, which also highlighted significant operational improvements, including a major new government contract, substantial margin expansion, and a new share repurchase program.
Key Details
- Reverse Stock Split: A 1-for-8 reverse stock split has been announced.
- New Contract Award: The company signed a 10-year, $54.6 million award with HHS, which will contribute over $5 million in annual recurring revenue starting November 2026.
- Financial Improvement: Gross margin increased to 29.1% in Q2 2026 from 6.1% in Q2 2025, and net debt has been reduced by more than 50% since year-end 2024.
- Capital Allocation: The Board authorized a $500,000 share repurchase program.